GlassScriptPhysician profile
John S Parker
NPI 1346509718
$72,068.42
in general payments reported to CMS, 2019-2025
32 companies · $3,271 in 2025
The $3,271 reported for 2025 was more than what 92% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,966 · 2020: $4,648 · 2021: $12K · 2022: $36K · 2023: $3,647 · 2024: $11K · 2025: $3,271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $7,475 · Food and Beverage: $6,077 · Consulting Fee: $4,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $7,474.85 |
| Food and Beverage | $6,077.30 |
| Consulting Fee | $4,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $40,627.17 | 2020-2025 | Ce-Marked Kxla System, Kxl System (Not Refurbished), Kxl System |
| Eyevance Pharmaceuticals LLC | $23,650.51 | 2019-2022 | |
| Ziemer USA | $1,517.59 | 2019 | |
| Dutch Ophthalmic Research Center (International) B.V. | $1,094.34 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $1,037.62 | 2021-2025 | Cirrus Hd-Oct, Iolmaster 700, Lumera 700 |
| Oculus, INC. | $1,000.00 | 2022 | |
| Alcon Vision LLC | $894.82 | 2021-2025 | Clareon, Clareon Panoptix Pro, Tryptyr |
| Carl Zeiss Meditec, INC. | $400.00 | 2020 | |
| Allergan, INC. | $226.47 | 2020-2022 | |
| Kala Pharmaceuticals, INC. | $225.76 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $198.86 | 2019-2023 | Cequa |
| Dompe US, INC. | $133.43 | 2019-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $129.85 | 2022-2024 | Vyzulta |
| Aerie Pharmaceuticals, INC. | $122.55 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $109.07 | 2019-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $103.00 | 2019-2022 | |
| Abbvie INC. | $95.66 | 2022 | |
| Mallinckrodt Hospital Products INC. | $56.96 | 2020-2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $52.45 | 2019-2021 | |
| Sight Sciences, INC. | $49.59 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Iridex Corporation | $48.44 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $42.30 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $31.64 | 2022 | |
| Ani Pharmaceuticals, INC. | $31.36 | 2025 | Purified Cortrophin Gel |
| Harrow Eye, LLC | $30.37 | 2025 | Vevye |
| Pacira Pharmaceuticals Incorporated | $28.88 | 2023 | Exparel |
| Takeda Pharmaceuticals U.S.A., INC. | $24.61 | 2023 | Gattex |
| New World Medical,INC. | $24.12 | 2024 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Thea Pharma INC. | $23.91 | 2023 | Iyuzeh |
| Baxter Healthcare | $20.84 | 2019 | |
| Mallinckrodt Enterprises LLC | $19.25 | 2019 | |
| Ocular Therapeutix, INC. | $17.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.